ABI
ESRX

Adamant Biomedical Investments’s Express Scripts Holding Company ESRX Stock Holding History

Adamant Biomedical Investments’s Portfolio ESRX Stock Details ESRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$4.83M Hold
57,000
– – 1.15% 31
2014
Q3 		$4.03M Buy
+57,000
New +$4.06M 1% 39

Other funds holding ESRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Adamant Biomedical Investments's ESRX Position: Q4 2014 in Review

Adamant Biomedical Investments held its Express Scripts Holding Company (ESRX) position steady in Q4 2014 at 57,000 shares worth $4.83M. The position accounts for 1.15% of the portfolio, ranked #31.

Adamant Biomedical Investments first reported a position in ESRX in Q3 2014 and has held it in 2 quarters since. 1,205 funds tracked by Wall St. Rank hold ESRX as of Q4 2014.

  • Adamant Biomedical Investments held 57,000 shares of Express Scripts Holding Company worth $4.83M as of Q4 2014.
  • Adamant Biomedical Investments left its Express Scripts Holding Company share count unchanged in Q4 2014.
  • Express Scripts Holding Company made up 1.15% of Adamant Biomedical Investments's portfolio in Q4 2014, its #31 holding.
  • Adamant Biomedical Investments first reported a position in Express Scripts Holding Company in Q3 2014 and has held it in 2 quarters since.
  • 1,205 funds tracked by Wall St. Rank held Express Scripts Holding Company as of Q4 2014.

Based on Adamant Biomedical Investments's 13F filing for Q4 2014, filed 13 Feb 2015.